Targeting DNA methylation can reduce cardiac injury associated with ischemia reperfusion: One step closer to clinical translation with blood-borne assessment

Ischemia reperfusion (I/R) injury is one of the main clinical challenges for cardiac surgeons. No effective strategies or therapy targeting the molecular and cellular mechanisms to reduce I/R exists to date, despite altered gene expression and cellular metabolism/physiology. We aimed to identify whe...

Descripción completa

Detalles Bibliográficos
Autores principales: Boovarahan, Sri Rahavi, AlAsmari, Abdullah F., Ali, Nemat, Khan, Rehan, Kurian, Gino A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554207/
https://www.ncbi.nlm.nih.gov/pubmed/36247432
http://dx.doi.org/10.3389/fcvm.2022.1021909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554207/
https://www.ncbi.nlm.nih.gov/pubmed/36247432
http://dx.doi.org/10.3389/fcvm.2022.1021909

Ejemplares similares